{"id":"W2070030853","doi":"10.1007/s10637-012-9856-0","title":"A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Tolerability; Pharmacokinetics; Neutropenia; Paclitaxel; Lung cancer; Adverse effect; Internal medicine; Toxicity; Population; Oncology; Pharmacology; Chemotherapy; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006968257,0.0001626227,0.0002371416,0.0002067265,0.00003712968,0.000009515885,0.00005053368,0.00003148723,0.00003381235],"category_scores_gemma":[0.00001071218,0.0001258323,0.00001656276,0.0004085974,0.00004796178,0.0002911373,0.0000143323,0.0001275358,0.000001318534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003534963,"about_ca_system_score_gemma":0.0004942712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009283752,"about_ca_topic_score_gemma":0.000118735,"domain_scores_codex":[0.9988596,0.00003732355,0.0003007757,0.0002047835,0.0003764385,0.0002211014],"domain_scores_gemma":[0.9993297,0.00005004687,0.0001834577,0.000127812,0.0001384905,0.0001705046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006120937,0.006741124,0.973419,0.0001242891,0.00007758423,0.000004323585,0.01403057,0.00167004,0.0008047365,0.00002810372,0.0001030871,0.002385108],"study_design_scores_gemma":[0.07865162,0.001343737,0.9142914,0.000712047,0.0002905158,0.000001011106,0.001217465,0.0008247439,0.002394967,0.00004230153,0.00005104882,0.0001791252],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973052,0.0002272522,0.00005720159,0.0002377169,0.00006198202,0.001584348,0.00002000829,0.00001394038,0.0004923609],"genre_scores_gemma":[0.9968289,0.000004128355,0.002375404,0.0001722476,0.00003814913,0.0002265303,0.0001292441,0.00002600139,0.0001994069],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07803953,"threshold_uncertainty_score":0.5131292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01128687864410548,"score_gpt":0.3151829202471673,"score_spread":0.3038960416030618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}